Cargando…

LY294002 Inhibits Intermediate Conductance Calcium-Activated Potassium (KCa3.1) Current in Human Glioblastoma Cells

Glioblastomas (GBs) are among the most common tumors with high malignancy and invasiveness of the central nervous system. Several alterations in protein kinase and ion channel activity are involved to maintain the malignancy. Among them, phosphatidylinositol 3-kinase (PI3K) activity and intermediate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caglioti, Concetta, Palazzetti, Federico, Monarca, Lorenzo, Lobello, Raffaele, Ceccarini, Maria Rachele, Iannitti, Rossana Giulietta, Russo, Roberta, Ragonese, Francesco, Pennetta, Chiara, De Luca, Antonella, Codini, Michela, Fioretti, Bernard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782274/ https://www.ncbi.nlm.nih.gov/pubmed/35069252 http://dx.doi.org/10.3389/fphys.2021.790922

Ejemplares similares

Resveratrol Supported on Magnesium DiHydroxide (Resv@MDH) Represents an Oral Formulation of Resveratrol With Better Gastric Absorption and Bioavailability Respect to Pure Resveratrol
por: Iannitti, Rossana Giulietta, et al.
Publicado: (2020)

Expression and Role of the Intermediate-Conductance Calcium-Activated Potassium Channel KCa3.1 in Glioblastoma
por: Catacuzzeno, Luigi, et al.
Publicado: (2012)

Solid Dispersion of Resveratrol Supported on Magnesium DiHydroxide (Resv@MDH) Microparticles Improves Oral Bioavailability
por: Spogli, Roberto, et al.
Publicado: (2018)

Synergistic Lethality of Mifepristone and LY294002 in Ovarian Cancer Cells
por: Wempe, Stacy L., et al.
Publicado: (2013)

Combined low-dose LiCl and LY294002 for the treatment of osteoporosis in ovariectomized rats
por: Bai, Jianhai, et al.
Publicado: (2019)

Effect of Oxaliplatin, Olaparib and LY294002 in Combination on Triple-Negative Breast Cancer Cells
por: Andreidesz, Kitti, et al.
Publicado: (2021)

LY294002 alleviates bone cancer pain by reducing mitochondrial dysfunction and the inflammatory response
por: Zhao, Jiajia, et al.
Publicado: (2023)

Cranberry/Chondroitin Sulfate Co-precipitate as a New Method for Controlling Urinary Tract Infections
por: Caglioti, Concetta, et al.
Publicado: (2023)

Histidine phosphorylation relieves copper inhibition in the mammalian potassium channel KCa3.1
por: Srivastava, Shekhar, et al.
Publicado: (2016)

The calcium-activated potassium channel KCa3.1 is an important modulator of hepatic injury
por: Sevelsted Møller, Linda, et al.
Publicado: (2016)

Modulating effect of the PI3-kinase inhibitor LY294002 on cisplatin in human pancreatic cancer cells
por: Fujiwara, Masao, et al.
Publicado: (2008)

Phosphatidylinositol 3-kinase inhibitor(LY294002) induces apoptosis of human nasopharyngeal carcinoma in vitro and in vivo
por: Jiang, Hanguo, et al.
Publicado: (2010)

LY294002 induces differentiation and inhibits invasion of glioblastoma cells by targeting GSK-3beta and MMP
por: Tian, Qi, et al.
Publicado: (2012)

LY294002 inhibits the Warburg effect in gastric cancer cells by downregulating pyruvate kinase M2
por: Lu, Jian, et al.
Publicado: (2018)

Contribution of the KCa3.1 channel–calmodulin interactions to the regulation of the KCa3.1 gating process
por: Morales, Patricia, et al.
Publicado: (2013)

The intermediate‐conductance calcium‐activated potassium channel KCa3.1 contributes to alkalinization‐induced vascular calcification in vitro
por: Bai, Yaling, et al.
Publicado: (2021)

KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo
por: D'Alessandro, G, et al.
Publicado: (2013)

Crystal structure of the C-terminal four-helix bundle of the potassium channel KCa3.1
por: Ji, Tianyang, et al.
Publicado: (2018)

LY294002 and sorafenib as inhibitors of intracellular survival pathways in the elimination of human glioma cells by programmed cell death
por: A, Zając, et al.
Publicado: (2021)

Reversion of glucocorticoid-induced senescence and collagen synthesis decrease by LY294002 is mediated through p38 in skin
por: Le, Quoc-Vu, et al.
Publicado: (2022)

Pharmacological targeting of the mitochondrial calcium-dependent potassium channel KCa3.1 triggers cell death and reduces tumor growth and metastasis in vivo
por: Bachmann, Magdalena, et al.
Publicado: (2022)

SN50 enhances the effects of LY294002 on cell death induction in gastric cancer cell line SGC7901
por: Zhao, Kui, et al.
Publicado: (2013)

Encapsulation of PI3K Inhibitor LY294002 within Polymer Nanoparticles Using Ion Pairing Flash Nanoprecipitation
por: Fergusson, Austin D., et al.
Publicado: (2023)

The potassium channel KCa3.1 constitutes a pharmacological target for astrogliosis associated with ischemia stroke
por: Yi, Mengni, et al.
Publicado: (2017)

Correction: Crystal structure of the C-terminal four-helix bundle of the potassium channel KCa3.1
por: Ji, Tianyang, et al.
Publicado: (2018)

Novel Phenolic Inhibitors of Small/Intermediate-Conductance Ca(2+)-Activated K(+) Channels, KCa3.1 and KCa2.3
por: Oliván-Viguera, Aida, et al.
Publicado: (2013)

LY 294002 inhibits adenosine receptor activation by a mechanism independent of effects on PI-3 kinase or casein kinase II
por: Searl, T. J., et al.
Publicado: (2005)

LY-294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K/AKT/HIF-1α pathway
por: Xu, Ruyue, et al.
Publicado: (2021)

Inhibition of the PI3K/Akt pathway by Ly294002 does not prevent establishment of persistent Junín virus infection in Vero cells
por: Linero, Florencia N., et al.
Publicado: (2014)

The Inhibition of KCa3.1 Channels Activity Reduces Cell Motility in Glioblastoma Derived Cancer Stem Cells
por: Ruggieri, Paola, et al.
Publicado: (2012)

Resveratrol-Based Multivitamin Supplement Increases Sperm Concentration and Motility in Idiopathic Male Infertility: A Pilot Clinical Study
por: Illiano, Ester, et al.
Publicado: (2020)

Investigating CFTR and KCa3.1 Protein/Protein Interactions
por: Klein, Hélène, et al.
Publicado: (2016)

Repurposing the KCa3.1 inhibitor senicapoc for Alzheimer's disease
por: Jin, Lee‐Way, et al.
Publicado: (2019)

Synergistic inhibition of colon carcinoma cell growth by Hedgehog-Gli1 inhibitor arsenic trioxide and phosphoinositide 3-kinase inhibitor LY294002
por: Cai, Xinyi, et al.
Publicado: (2015)

Autophagy Inhibitor (LY294002) and 5-fluorouracil (5-FU) Combination-Based Nanoliposome for Enhanced Efficacy Against Esophageal Squamous Cell Carcinoma
por: Feng, Ye, et al.
Publicado: (2018)

Tamoxifen and the PI3K Inhibitor: LY294002 Synergistically Induce Apoptosis and Cell Cycle Arrest in Breast Cancer MCF-7 Cells
por: Abdallah, Mohamed E., et al.
Publicado: (2020)

Potassium channels Kv1.3 and KCa3.1 cooperatively and compensatorily regulate antigen-specific memory T cell functions
por: Chiang, Eugene Y., et al.
Publicado: (2017)

Ca(2+)-activated KCa3.1 potassium channels contribute to the slow afterhyperpolarization in L5 neocortical pyramidal neurons
por: Roshchin, M. V., et al.
Publicado: (2020)

Focus on the Use of Resveratrol in Bladder Cancer
por: Zucchi, Alessandro, et al.
Publicado: (2023)

Versatile inhibitory effects of the flavonoid-derived PI3K/Akt inhibitor, LY294002, on ATP-binding cassette transporters that characterize stem cells
por: Imai, Yasuo, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_3f8uuf6b116akjr1tlbh52kn6u